Nebulized granulocyte macrophage-colony stimulating factor to stabilize lung function in nontuberculous mycobacteria pulmonary disease in cystic fibrosis

Pediatr Pulmonol. 2024 Nov;59(11):3001-3003. doi: 10.1002/ppul.27135. Epub 2024 Jun 21.
No abstract available

Keywords: cystic fibrosis; nontuberculous mycobacteria pulmonary disease.

Publication types

  • Letter

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Child
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / microbiology
  • Cystic Fibrosis* / physiopathology
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor*
  • Humans
  • Lung Diseases / drug therapy
  • Lung Diseases / microbiology
  • Lung Diseases / physiopathology
  • Male
  • Mycobacterium Infections, Nontuberculous* / drug therapy
  • Nebulizers and Vaporizers
  • Nontuberculous Mycobacteria

Substances

  • Granulocyte-Macrophage Colony-Stimulating Factor

Grants and funding